…
CRA International, Inc., together with its subsidiaries, provides economic, financial, and management consulting services worldwide. It advises clients on economic and financial matters pertaining to litigation and regulatory proceedings; and guide corporations through business strategy and performance-related issues. The company also offers consulting services, including research and analysis, expert testimony, and comprehensive support in litigation and regulatory proceedings in the areas of finance, accounting, economics, insurance, and forensic accounting and investigations to corporate clients and attorneys. In addition, it provides management consulting services, such as strategy development, performance improvement, corporate strategy and portfolio analysis, estimation of market demand, environmental, social and corporate governance and sustainability strategy and analysis, design and implementation of auction and bidding, new product pricing strategies, survey and market research, valuation of intellectual property and other assets, assessment of competitors' actions, and analysis of new sources of supply. The company serves various industries comprising blockchain and cryptocurrency; communications and media; consumer, health, and wellness products; energy; entertainment and leisure; financial services; healthcare; life sciences; manufacturing and industries; natural resources; retail and distribution; technology; and transportation. The company was incorporated in 1965 and is headquartered in Boston, Massachusetts.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
CRA International, Inc. provides economic, financial and management consulting including litigation support and regulatory advisory to corporations, law firms and governments. Long-term growth could be supported by sustained regulatory scrutiny, complex litigation and M&A activity that drive demand for quantitative expert testimony, and investors may find the company attractive because it appears positioned to deliver expertise-driven, repeat engagements.
Principal risks include reliance on billable consultant utilization and key-person expertise, revenue cyclicality tied to litigation and deal activity, competitive pressure from larger firms and client concentration; investors should monitor talent retention.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 76.57M | 66.24M | 52.29M | 58.80M | 54.27M |
| Net income | 54.78M | 46.65M | 38.48M | 43.62M | 41.68M |
| Selling general administrative | 135.03M | 125.05M | 114.20M | 110.09M | 97.37M |
| Gross profit | 218.16M | 207.48M | 171.73M | 180.82M | 165.88M |
| Reconciled depreciation | 29.51M | 26.82M | 25.80M | 25.75M | 25.78M |
| Ebit | 81.93M | 70.66M | 56.10M | 58.74M | 55.74M |
| Ebitda | 96.07M | 97.48M | 81.94M | 70.73M | 68.51M |
| Depreciation and amortization | 14.14M | 26.82M | 25.84M | 12.00M | 12.77M |
| Non operating income net other | - | - | - | 1.89M | -0.49M |
| Operating income | 83.12M | 70.75M | 56.61M | 58.74M | 55.74M |
| Other operating expenses | 668.46M | 616.66M | 567.37M | 532.16M | 510.19M |
| Interest expense | 5.36M | 4.42M | 3.81M | 1.83M | 0.97M |
| Tax provision | 21.79M | 19.59M | 12.18M | 15.18M | 12.60M |
| Net interest income | -5.36M | -4.42M | -3.69M | -1.83M | -0.97M |
| Income tax expense | 21.79M | 19.59M | 13.81M | 15.18M | 12.60M |
| Total revenue | 751.58M | 687.41M | 623.98M | 590.90M | 565.93M |
| Total operating expenses | 135.03M | 136.73M | 115.12M | 122.08M | 110.14M |
| Cost of revenue | 533.43M | 479.94M | 452.25M | 410.08M | 400.05M |
| Total other income expense net | -6.55M | -4.51M | -4.32M | 0.06M | -1.46M |
| Net income from continuing ops | 54.78M | 46.65M | 35.70M | 43.62M | 41.68M |
| Net income applicable to common shares | - | - | - | 43.62M | 41.68M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 628.87M | 571.44M | 553.21M | 550.92M | 555.36M |
| Intangible assets | 5.69M | 7.22M | 7.20M | 8.59M | 4.18M |
| Other current assets | 36.06M | 16.57M | 11.57M | 22.43M | 21.16M |
| Total liab | 415.27M | 359.37M | 341.11M | 339.76M | 349.53M |
| Total stockholder equity | 213.60M | 212.07M | 212.10M | 211.15M | 205.83M |
| Deferred long term liab | - | - | - | 0.95M | 11.98M |
| Other current liab | 248.63M | 204.46M | 184.21M | 161.55M | 162.42M |
| Common stock | 2.48M | 1.66M | - | 1.74M | - |
| Capital stock | 2.48M | 1.66M | 0.00M | 1.74M | 0.00M |
| Retained earnings | 221.06M | 225.46M | 224.28M | 224.39M | 215.78M |
| Other liab | - | - | - | 16.63M | 11.98M |
| Good will | 94.72M | 93.74M | 93.99M | 92.90M | 88.94M |
| Other assets | - | - | - | 0.02M | 48.81M |
| Cash | 18.21M | 26.71M | 45.59M | 31.45M | 66.13M |
| Total current liabilities | 330.03M | 251.31M | 236.09M | 217.12M | 213.09M |
| Current deferred revenue | - | 14.13M | 6.70M | 12.02M | 12.82M |
| Net debt | 109.02M | 76.53M | 63.17M | 90.53M | 72.67M |
| Short term debt | 51.22M | 18.70M | 16.48M | 15.97M | 14.34M |
| Short long term debt | 34.00M | - | - | - | - |
| Short long term debt total | 127.23M | 103.24M | 108.75M | 121.98M | 138.80M |
| Other stockholder equity | - | - | - | 200.68M | 205.83M |
| Property plant equipment | - | - | - | 45.58M | 53.61M |
| Total current assets | 303.13M | 269.36M | 265.48M | 248.86M | 249.35M |
| Net tangible assets | - | - | - | 109.64M | 112.72M |
| Net receivables | 248.86M | 226.08M | 208.31M | 194.99M | 162.06M |
| Inventory | - | - | 0.00M | - | - |
| Accounts payable | 30.18M | 28.16M | 28.70M | 27.58M | 23.51M |
| Accumulated other comprehensive income | -9.94M | -15.05M | -12.18M | -14.98M | -9.95M |
| Common stock total equity | - | - | - | 1.74M | - |
| Retained earnings total equity | - | - | - | 224.39M | 215.78M |
| Non currrent assets other | 112.50M | 9.16M | 2.42M | 49.08M | 48.81M |
| Non current assets total | 325.74M | 302.08M | 287.74M | 302.06M | 306.01M |
| Capital lease obligations | 93.23M | 103.24M | 108.75M | 121.98M | 138.80M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -18.12M | -7.57M | -18.16M | -2.62M |
| Change to liabilities | - | - | - | 2.25M | 14.88M |
| Total cashflows from investing activities | -3.87M | -18.12M | -2.94M | -18.16M | -2.62M |
| Net borrowings | 34.00M | 0.00M | 0.00M | -1.01M | - |
| Total cash from financing activities | -29.84M | -48.86M | -44.48M | -38.95M | -51.99M |
| Change to operating activities | - | - | - | -20.93M | -0.45M |
| Net income | 54.68M | 46.65M | 38.48M | 43.62M | 41.68M |
| Change in cash | -8.50M | -18.88M | 14.14M | -34.68M | 20.45M |
| Begin period cash flow | 26.71M | 45.59M | 31.45M | 66.13M | 45.68M |
| End period cash flow | 18.21M | 26.71M | 45.59M | 31.45M | 66.13M |
| Total cash from operating activities | 22.42M | 49.73M | 60.07M | 25.12M | 75.70M |
| Depreciation | 29.51M | 26.82M | 25.84M | 25.75M | 25.78M |
| Other cashflows from investing activities | - | -1.50M | - | -14.35M | - |
| Dividends paid | 13.83M | 12.30M | 10.81M | -9.58M | -8.29M |
| Change to inventory | - | - | 0.00M | - | -19.27M |
| Change to account receivables | -79.08M | -21.40M | 2.21M | -24.93M | -5.69M |
| Sale purchase of stock | -47.15M | -33.35M | -31.42M | -27.63M | -44.98M |
| Other cashflows from financing activities | -2.86M | -3.21M | -2.26M | 122.85M | -3.88M |
| Change to netincome | - | - | - | 4.74M | 3.90M |
| Capital expenditures | 3.87M | 16.62M | 2.37M | 3.81M | 2.62M |
| Change receivables | - | - | - | -24.93M | -5.69M |
| Cash flows other operating | - | - | - | -12.56M | 8.16M |
| Cash and cash equivalents changes | - | - | - | -32.00M | 21.08M |
| Change in working capital | -67.33M | -26.23M | -4.61M | -48.99M | 4.34M |
| Stock based compensation | 5.87M | 5.29M | 4.40M | 4.77M | 4.09M |
| Other non cash items | 1.43M | 0.07M | 0.59M | -0.22M | -0.63M |
| Free cash flow | 18.56M | 33.11M | 57.71M | 21.31M | 73.08M |
Sector: Industrials Industry: Consulting Services
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CRAI CRA International Inc |
-5.28 2.60% |
197.66 | 22.18 | 17.42 | 1.30 | 5.74 | 1.67 | 12.24 |
| EXPGF Experian PLC |
- -% |
42.30 | 26.59 | 19.34 | 4.43 | 6.44 | 4.99 | 14.01 |
| EXPGY Experian plc PK |
-1.27 3.03% |
40.58 | 26.45 | 19.30 | 4.41 | 6.43 | 4.99 | 14.01 |
| VRSK Verisk Analytics Inc |
-6.88 3.25% |
204.59 | 28.72 | 21.88 | 7.52 | 74.89 | 9.06 | 16.91 |
| EFX Equifax Inc |
-4.25 2.19% |
189.59 | 30.32 | 17.18 | 3.05 | 4.62 | 3.96 | 13.37 |
CRA International, Inc., together with its subsidiaries, provides economic, financial, and management consulting services worldwide. It advises clients on economic and financial matters pertaining to litigation and regulatory proceedings; and guide corporations through business strategy and performance-related issues. The company also offers consulting services, including research and analysis, expert testimony, and comprehensive support in litigation and regulatory proceedings in the areas of finance, accounting, economics, insurance, and forensic accounting and investigations to corporate clients and attorneys. In addition, it provides management consulting services, such as strategy development, performance improvement, corporate strategy and portfolio analysis, estimation of market demand, environmental, social and corporate governance and sustainability strategy and analysis, design and implementation of auction and bidding, new product pricing strategies, survey and market research, valuation of intellectual property and other assets, assessment of competitors' actions, and analysis of new sources of supply. The company serves various industries comprising blockchain and cryptocurrency; communications and media; consumer, health, and wellness products; energy; entertainment and leisure; financial services; healthcare; life sciences; manufacturing and industries; natural resources; retail and distribution; technology; and transportation. The company was incorporated in 1965 and is headquartered in Boston, Massachusetts.
| Name | Title | Year Born |
|---|---|---|
| Mr. Paul A. Maleh | Chairman, Pres & CEO | 1964 |
| Mr. Daniel K. Mahoney | CFO, Exec. VP & Treasurer | 1979 |
| Mr. Jonathan D. Yellin | Exec. VP & Gen. Counsel | 1964 |
| Mr. Chad Holmes | Exec. VP & Chief Corp. Devel. Officer | 1973 |
| Ms. Mary Beth Savio | VP & Director of Operations | NA |
| Mr. Samuel Lynch | Principal | NA |
| Mr. Elahd Toam | Principal | NA |
| Ms. Cristina Caffarra | VP & Head of European Competition Practice | NA |
| Dr. Miguel Herce | Principal | NA |
| Dr. Xiao-Ru Wang | Principal | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.